Document is current
Any future updates will be listed below
-
Authors
Cheng, Binbin
Wang, Wei
Liu, Ting
Cao, Hao
Pan, Wei
Xiao, Yao
Liu, Shuwen https://orcid.org/0000-0001-6346-5006
Chen, Jianjun https://orcid.org/0000-0001-5668-6572
-
Funding
Funding for this research was provided by:
the National Natural Science Foundation of China
the talent introduction program from Hubei Polytechnic University (No. 22xjz15R); and the Hubei Key Laboratory of Kidney Disease Pathogenesis and Intervention
the Foshan Medical Science and Technology Project grants, the Foshan Outstanding Young Medical Talents Project grants
the Wuhan Municipal Health Commission of China
the Scientific and Technological Key Projects of Guangdong Province
- License Information
-
More Information
Article History
Received: 12 July 2022
Revised: 22 November 2022
Accepted: 7 December 2022
First Online: 1 March 2023
Competing interests
: The authors declare no competing interests.
: Protocols for animal experiments (B16-F10 and CT-26 tumor model) were approved by the NIACEC (National Institutional Animal Care & Ethical Committee) at SMU (Southern Medical University) and Hubei Polytechnic University (Assurance Number: HBPU-IACUC-MED-2022-1122). All animal studies were conducted strictly in accordance with the guidelines set by the Chinese Regulations of Laboratory Animals and Laboratory Animal Requirements of Environment and Housing Facilities.
